+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Preparation, Characterization and in vivo Evaluation of Simple Monolithic Ethylcellulose-coated Pellets Containing Topiramate with Biphasic Release Characteristics



Preparation, Characterization and in vivo Evaluation of Simple Monolithic Ethylcellulose-coated Pellets Containing Topiramate with Biphasic Release Characteristics



Current Drug Delivery 13(2): 245-254



In our previous study, polyvinylpyrrolidone (PVP) was used both as a binder and a pore-former to prepare ethylcellulose (EC)-coated pellets to deliver topiramate (TPM) for a controlled release profile. The objective of this work was to further optimize the formulation and evaluate the in vivo profiles of TPM sustained-release pellets. Similar to the previous formulation with no binder, the in vitro drug release of TPM sustained-release pellets with 50% PVP binder in drug layer was sensitive to pore-former PVP level ranged from 27.0% to 29.0%. The higher the level of PVP was, the quicker release rate in vitro was. Moreover, when the proportion of poreformer PVP decreased, the Cmax decreased, and the tmax and mean residence time of TPM coated pellets were both prolonged. The in vitro release profile of optimal formulation showed biphasic release characteristics similar to reference formulation Trokendi XR(®), i.e., involving immediate release of TPM in initial release stage followed by a sustained release up to 24 h. Moreover, the impact of the pH of release medium on the drug release rate of TPM sustained-release pellets was not significant. The release mechanism of TPM from the sustained-release pellets might be the interaction of diffusion (coating-film) and corrosion (drug layer). The in vivo pharmacokinetics results showed the TPM sustained-release pellets had the similar in vivo pattern compared with Trokendi XR(®). These studies provide valuable basis for further development of TPM sustained-release pellets.

(PDF emailed within 1 workday: $29.90)

Accession: 058609041

Download citation: RISBibTeXText

PMID: 26563941


Related references

Novel ethylcellulose-coated pellets for controlled release of metoprolol succinate without lag phase: characterization, optimization and in vivo evaluation. Drug Development and Industrial Pharmacy 41(7): 1120-1129, 2016

Biphasic drug release: permeability and swelling of pectin/ethylcellulose films, and in vitro and in vivo correlation of film-coated pellets in dogs. Chemical and Pharmaceutical Bulletin 56(8): 1118-1125, 2008

Effects of polyvinylpyrrolidone both as a binder and pore-former on the release of sparingly water-soluble topiramate from ethylcellulose coated pellets. International Journal of Pharmaceutics 465(1-2): 187-196, 2014

Preparation, Characterization and Pharmacokinetics Evaluation of the Compound Capsules of Ibuprofen Enteric-Coated Sustained-Release Pellets and Codeine Phosphate Immediate-Release Pellets. Aaps Pharmscitech 19(7): 3057-3066, 2018

Development and evaluation of ethylcellulose coated controlled release pellets. Indian Journal of Pharmaceutical Sciences 62(2): 147-149, March-April, 2000

Assessment of the in-vivo drug release from pellets film-coated with a dispersion of high amylose starch and ethylcellulose for potential colon delivery. Journal of Pharmacy and Pharmacology 62(1): 55-61, 2010

Circumvention of pH-dependent release from ethylcellulose-coated pellets. Journal Of Controlled Release. 36(3): 251-260, 1995

Prediction of drug release from ethylcellulose coated pellets. Journal of Controlled Release 135(1): 71-79, 2009

Mechanism of release from pellets coated with an ethylcellulose-based film. Journal of Controlled Release 14(3): 203-213, 1990

Mechanism of release from pellets coated with an ethylcellulose based film. Journal of Controlled Release 14(3): 203-214, 1990

Correlation of 'in vitro' release and 'in vivo' absorption characteristics of rifampicin from ethylcellulose coated nonpareil beads. International Journal of Pharmaceutics (Kidlington) 230(1-2): 1-9, 6 November, 2001

Drug release mechanisms from ethylcellulose: PVA-PEG graft copolymer-coated pellets. European Journal of Pharmaceutics and Biopharmaceutics 72(1): 130-137, 2009

Effect of substrate on mass release from ethylcellulose latex coated pellets. Journal Of Controlled Release. 32(1): 71-77, 1994

Influence of pH and plasticizers on drug release from ethylcellulose pseudolatex coated pellets. Journal Of Pharmaceutical Sciences. 83(10): 1386-1390, 1994

Preparation, Characterization and In Vitro / In Vivo Evaluation of Oral Time-Controlled Release Etodolac Pellets. Aaps Pharmscitech 19(2): 610-620, 2017